External Genital Warts: Report of the American Medical Association Consensus Conference

Abstract

A consensus process was undertaken to describe and evaluate current information and practice regarding the diagnosis, treatment, and evaluation of patients with external genital warts (EGWs) and their sex partners. This process developed a number of key statements that were based on strong evidence in the literature or reasonable suppositions and opinions of experts. Key statements included the following. In most cases, EGWs can be diagnosed clinically by visual inspection. No one treatment is ideal for all patients or all warts. Women with EGWs and female sex partners of men with EGWs are at increased risk for human papillomavirus-related cervical disease and, like all women, should be screened for cervical cancer. The diagnosis of EGWs in children requires a sexual abuse evaluation. Clinicians who treat EGWs have a responsibility to counsel patients and to provide information about the infectivity, diagnosis, treatment, and natural history of EGWs and general information about sexual health and other sexually transmitted diseases.

What college women know, think and do about human papillomavirus (HPV) and HPV vaccine

“…Most, 99.7%, of cervical cancers show HPV DNA sequences from a high-risk oncogenic genital HPV. The most prevalent types are HPV 16, found in 55-70%, and HPV 18, found in 7-20%, of cervical cancer cases (Ault, 2006;Beutner et al, 1998).…”

“…Low risk HPVs can result in mild cervical abnormalities but it does not lead to cancer (Ault, 2006;Beutner et al, 1998). The most common outcome of low-risk HPV infection is condyloma acuminata.…”

“…More than 100 different HPV types have been identified and approximately thirty types infect the genital tissues. High-risk, oncogenic HPV types (e.g., HPV 16 and HPV 18) are responsible for 99.7% of all cervical cancers while low-risk HPV types (e.g., HPV 6 and HPV 11) can result in mild cervical abnormalities, genital and respiratory tract warts (Ault, 2006;Beutner, Reitano, & Richwald, 1998). Approximately twenty million (15%) of Americans, between the ages of 15 and 49 are currently infected with HPV and another six million people become newly infected each year (Weinstock et al, 2004).…”

Pregnancy with HPV associated Viral Warts

“…Patients who have visible genital warts are frequently infected simultaneously with multiple HPV types [6].…”

Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2–3

“…The first and most significant of them is a false negative result which precludes women with undiagnosed lesions from being referred for a proper evaluation, with the consequent obvious risk of developing invasive cervical disease. In addition, cervical cytology is associated with a substantial false positive rate that may create an overload in the work schedule of the limited available colposcopic units, causing a delay in the referral of true positive cases for colposcopic evaluation and leading to overtreatment, which is inevitably accompanied by anxiety, morbidity and monetary costs (Beutner et al, 1998).…”